+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PTC Therapeutics - logo

PTC Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product candidate is Translarna (ataluren), which is for the treatment of of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is currently in Phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.

Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions - Product Thumbnail Image

Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions

  • Report
  • September 2024
  • 375 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 220 Pages
  • Global
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2026-2030 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 277 Pages
  • Global
From
Neuromuscular Disease Therapeutics Market 2025-2029 - Product Thumbnail Image

Neuromuscular Disease Therapeutics Market 2025-2029

  • Report
  • December 2024
  • 195 Pages
  • Global
From
Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • May 2025
  • 115 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2025-2033 - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2025-2033

  • Report
  • January 2025
  • 143 Pages
  • Global
From
Duchenne Muscular Dystrophy Market Report 2026 - Product Thumbnail Image

Duchenne Muscular Dystrophy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2026 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Huntington Disease Medications Market - Global Forecast 2026-2032 - Product Thumbnail Image

Huntington Disease Medications Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) - Pipeline Insight, 2025 - Product Thumbnail Image

Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Transthyretin Amyloidosis Treatment Market Report 2026 - Product Thumbnail Image

Transthyretin Amyloidosis Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 64 Pages
  • Global
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 302 Pages
  • Global
From
Friedreich Ataxia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Friedreich Ataxia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 108 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2025

  • Report
  • October 2025
  • 500 Pages
  • Global
From
U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031 - Product Thumbnail Image

U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031

  • Drug Pipelines
  • February 2026
  • 3300 Pages
  • United States
From
Duchenne Muscular Dystrophy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Duchenne Muscular Dystrophy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 170 Pages
  • Global
Dravet Syndrome Market - Global Strategic Business Report - Product Thumbnail Image

Dravet Syndrome Market - Global Strategic Business Report

  • Report
  • March 2026
  • 485 Pages
  • Global
From
Leigh Syndrome Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Leigh Syndrome Treatment Market - Global Strategic Business Report

  • Report
  • March 2026
  • 477 Pages
  • Global
From
Loading Indicator